MedTrace Logo

Preventing Depression in Patients With Macular Degeneration

NCT00042211 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2014-01-08

No results posted yet for this study

Summary

This study will evaluate the effectiveness of a Problem Solving Treatment in preventing depression in elderly patients with age-related macular degeneration (AMD).

Conditions

Interventions

BEHAVIORAL

Problem Solving Treatment

Brief Cognitive Behavioral Therapy

BEHAVIORAL

Control

No treatment control

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • barry rovner, md · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-02-28
Primary Completion
2006-01-31
Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00042211 on ClinicalTrials.gov